Roche’s personalized cancer treatment wins FDA approval
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in…
FDA proposes graphic warnings on cigarette packs, advertisements
(Reuters) – The U.S. Food and Drug Administration has proposed that cigarette packs carry graphic new health warnings including pictures…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use
(Reuters) – Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of…
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United…
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
(Reuters) – A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying…
Senator Grassley seeks info on Novartis’s Zolgensma data issues
FILE PHOTO: U.S. Senator Chuck Grassley (R-IA) speaks to reporters on his way from the Senate floor after a vote…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to…
Patient groups push back against Gilead’s pricey HIV prevention treatment
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in…
Nobio gets FDA approval for anti-bacterial dental fillings
TEL AVIV (Reuters) – Israel’s Nobio Ltd said on Monday it received approval from the U.S. Food and Drug Administration…
Roche says test showed Tecentriq helped vs bladder cancer
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor
(Reuters) – The U.S. Food and Drug Administration on Friday approved Daiichi Sankyo Co Ltd’s treatment for adult patients with…
Oklahoma makes final bid to hold J&J responsible for opioid epidemic
(Reuters) – Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion…
Bernie Sanders visits Canadian pharmacy, talks drug prices
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the…
Roche’s Tecentriq recommended for EU approval to treat lung cancer form
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in…
In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million
(Reuters) – A California judge on Thursday reduced a $2 billion jury verdict, slashing the award for a couple who…
Allergan recalls textured breast implants worldwide
(Reuters) – Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets,…
Eli Lilly’s hypoglycemia treatment wins FDA approval
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
Some women don’t heed warnings of acne drug danger during pregnancy conception
(Reuters Health) – It’s long been known that the highly effective acne medication isotretinoin – marketed as Accutane and Roaccutane…
Biohaven’s treatment for Lou Gehrig’s disease fails to win FDA nod
FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company’s IPO on the…
Opioid ‘kingpin’ J&J fueled epidemic, Oklahoma argues at trial’s end
NORMAN, Okla. (Reuters) – Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson (JNJ.N) to a drug…
U.S. judge slashes Roundup jury award to $25.3 million from $80.3 million
FILE PHOTO: A logo of Bayer AG is pictured at the so called ‘Chempark’, the main plant and headquarters of…
Eton’s conjunctivitis treatment fails to win FDA nod; shares tumble
(Reuters) – Eton Pharmaceuticals Inc said on Friday that the U.S. Food and Drug Administration declined to approve its treatment…
Lawmakers seek scientific review of plan to tightly regulate all fentanyl copycats
WASHINGTON (Reuters) – Lawmakers on the U.S. Senate Judiciary Committee have urged the Trump administration to conduct a scientific review…
White House scraps key plan to lower U.S. drug prices; may target drugmakers
NEW YORK/WASHINGTON (Reuters) – The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine…
Juror urges U.S. judge to uphold $80 million Roundup verdict against Bayer
(Reuters) – A juror who was part of a panel that delivered an $80 million award against Bayer AG after…
CannTrust slumps after Health Canada finds unlicensed pot cultivation
(Reuters) – CannTrust Holdings Inc’s shares plunged about 23% to a more than one-and-half-year low on Monday, after Health Canada…
Trump administration drug officials clash over how to combat fentanyl copycats
WASHINGTON (Reuters) – Trump administration officials are divided over part of a proposal to crack down on illicit versions of…
U.S. judge strikes down Trump administration rule requiring drug prices in TV ads
(Reuters) – A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule…
Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local…
Novartis to sell epinephrine injector in U.S. pharmacies amid EpiPen shortage
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen…
FDA ties three deaths to Edwards Lifesciences’ recalled heart devices
(Reuters) – The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences…
French health watchdog recommends ending reimbursement for homeopathic drugs
PARIS (Reuters) – France’s health watchdog on Friday recommended that social security stop reimbursing patients for homeopathic drugs, citing insufficient…
Teleflex recalls breathing tubes worldwide after reports of 4 deaths
(Reuters) – Teleflex Inc said on Monday it plans to recall some lots of its Hudson RCI Sheridan endotracheal tubes…
FDA declines to approve Daiichi Sankyo’s blood cancer treatment
(Reuters) – Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its…
U.S. group says Novartis MS drug price out of line with benefit
ZURICH (Reuters) – A U.S. group that reviews the value of medicines issued a critical report on Novartis’s new multiple…
FDA approves drug for loss of sexual desire in women
(Reuters) – The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in…
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal…
Israel’s Zebra Medical gets FDA ok for brain bleeds product
TEL AVIV (Reuters) – Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78…
Health Canada to allow some edible cannabis products starting mid-December
FILE PHOTO: Cannabis plants fill a room in an aquaponics grow operation by licensed marijuana producer Green Relief in Flamborough,…
Roche’s combo lymphoma treatment wins U.S. FDA approval
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
U.S. drugmakers file lawsuit against requiring drug prices in TV ads
FILE PHOTO: Used blister packets that contained medicines, tablets and pills are seen, in this picture illustration taken June 30,…
U.S. cities propose framework for nationwide opioid settlement talks
(Reuters) – Lawyers for counties and municipalities suing drug manufacturers and distributors over their alleged roles in the U.S. opioid…
Canadian panel calls for universal public drug coverage
OTTAWA/TORONTO (Reuters) – A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create a…
Top lawmaker signals support to classify all illicit fentanyl copycats like heroin
WASHINGTON (Reuters) – A top U.S. Senator signaled some support on Tuesday for legislation permanently placing illicit chemical knock-offs of…
FDA approves Lilly’s migraine drug as first ever cluster headache treatment
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S.…
U.S. football player’s overdose death spotlighted in J&J Oklahoma opioid trial
(Reuters) – The father of a college football player who died of a drug overdose gave emotional testimony about the…
J&J’s greed helped fuel U.S. opioid crisis, Oklahoma claims at trial
NORMAN, Okla. (Reuters) – Johnson & Johnson’s greed led the drugmaker to use deceptive marketing to create an oversupply of…
U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks
(Reuters) – A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the…
Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017.…
U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks
(Reuters) – A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the…